UBS Group’s Vicarious Surgical RBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08K | Sell |
144
-2,330
| -94% | -$17.5K | ﹤0.01% | 8348 |
|
|
2025
Q1 | $16.2K | Buy |
2,474
+2,444
| +8,147% | +$16K | ﹤0.01% | 7056 |
|
|
2024
Q4 | $395 | Buy |
+30
| New | +$395 | ﹤0.01% | 8242 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | -$6 | – | 8682 |
|
|
2024
Q2 | $6 | Sell |
1
-3,230
| -100% | -$19.4K | ﹤0.01% | 8224 |
|
|
2024
Q1 | $29.2K | Sell |
3,231
-696
| -18% | -$6.29K | ﹤0.01% | 5586 |
|
|
2023
Q4 | $43.2K | Buy |
3,927
+2,358
| +150% | +$26K | ﹤0.01% | 5424 |
|
|
2023
Q3 | $27.8K | Buy |
1,569
+196
| +14% | +$3.48K | ﹤0.01% | 5491 |
|
|
2023
Q2 | $75.4K | Sell |
1,373
-777
| -36% | -$42.6K | ﹤0.01% | 5161 |
|
|
2023
Q1 | $146K | Sell |
2,150
-4,521
| -68% | -$308K | ﹤0.01% | 4574 |
|
|
2022
Q4 | $404K | Buy |
6,671
+2,779
| +71% | +$168K | ﹤0.01% | 3859 |
|
|
2022
Q3 | $391K | Buy |
3,892
+188
| +5% | +$18.9K | ﹤0.01% | 3570 |
|
|
2022
Q2 | $326K | Buy |
3,704
+561
| +18% | +$49.4K | ﹤0.01% | 3637 |
|
|
2022
Q1 | $477K | Buy |
3,143
+3,140
| +104,667% | +$477K | ﹤0.01% | 3792 |
|
|
2021
Q4 | $1K | Sell |
3
-105
| -97% | -$35K | ﹤0.01% | 8892 |
|
|
2021
Q3 | $49K | Sell |
108
-454
| -81% | -$206K | ﹤0.01% | 5256 |
|
|
2021
Q2 | $168K | Buy |
562
+91
| +19% | +$27.2K | ﹤0.01% | 4463 |
|
|
2021
Q1 | $140K | Sell |
471
-1,138
| -71% | -$338K | ﹤0.01% | 4729 |
|
|
2020
Q4 | $491K | Buy |
1,609
+1,596
| +12,277% | +$487K | ﹤0.01% | 3686 |
|
|
2020
Q3 | $4K | Buy |
+13
| New | +$4K | ﹤0.01% | 6544 |
|